Jatcorp’s FY2025 Losses Surge $1.9M in H2 as Revenue Drops $39M
Jatcorp anticipates a significant net loss for FY2025 driven by halted sales in China and legal disputes, yet remains cautiously optimistic about growth prospects in FY2026.
- FY2025 net loss expected between $7.6M and $8M
- Revenue down $39M due to China sales suspension and international exit
- Goodwill impairment and $1.4M inventory write-down related to Neurio brand
- Legal expenses remain high at $4.1M despite some reduction
- Moroka brand growth and distributor targets underpin FY2026 optimism
Jatcorp’s Challenging FY2025
Jatcorp Limited (ASX, JAT), a producer of supplementary and plant-based food products, has revealed preliminary unaudited guidance pointing to a net loss after tax between $7.6 million and $8 million for the financial year ended June 30, 2025. This marks a notable deterioration from the first half of FY2025, where the company reported a $6.1 million loss, and a significant decline compared to FY2024’s audited results.
The primary driver behind this disappointing performance is a sharp revenue contraction of approximately $39 million. This decline stems largely from the cessation of Jatcorp’s international trading operations and the unexpected suspension of Neurio-branded product sales in China. The suspension follows an adverse interim ruling in ongoing legal disputes related to the Neurio brand, which has materially disrupted the company’s access to one of its key markets.
Financial Impairments and Legal Costs
Compounding the revenue hit, Jatcorp has recorded a goodwill impairment of over $2.3 million and a trade name impairment of $225,000 linked to the Sunnya cash generating unit, reflecting diminished recoverable value due to the China sales suspension. Additionally, the company took a non-cash inventory write-down of approximately $1.4 million, mostly tied to excess stock from the halted Neurio operations.
Legal and professional expenses, while reduced by about $1 million compared to the previous year, remain elevated at $4.1 million. These costs are primarily associated with ongoing litigation surrounding the Neurio brand dispute in China, underscoring the financial strain of protracted legal battles on the company’s bottom line.
Looking Ahead, FY2026 Outlook
Despite the setbacks, Jatcorp is cautiously optimistic about FY2026. Management is focusing on operational restructuring, brand development, and expanding distribution channels to drive recovery. The Moroka brand, in particular, has shown promising momentum with an expanding product range and increasing consumer engagement.
Jatcorp’s principal distributor, H&S International (HK) Co. Ltd., has reaffirmed its commitment to achieving an $11 million sales target for FY2026, representing a 22% increase over FY2025 sales. This target signals confidence in the company’s growth strategy and the potential for margin improvement.
The company plans to provide further details on its FY2026 strategy and operational guidance alongside the release of its audited FY2025 results, which remain subject to final audit adjustments.
Bottom Line?
Jatcorp’s FY2025 losses highlight the risks of international legal disputes, but FY2026 growth hinges on successful brand and distribution execution.
Questions in the middle?
- How will the final audited FY2025 results compare to the preliminary loss guidance?
- What is the likely timeline and outcome of the ongoing Neurio legal dispute in China?
- Can Moroka’s growth and distributor commitments fully offset the lost revenue from Neurio?